secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0001104659-23-070864
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immunome shareholders reject officer exculpation amendment at annual meeting
----------------------------------------------------------------------------

- Class III directors Richard A. Baron and Philip Wagenheim elected until 2026.
- Proposal to amend certificate for officer exculpation failed: 3,528,592 for, 86,542 against, 4,115,553 broker non-votes.
- Ratification of Ernst & Young as independent auditor for FY2023 approved: 7,578,396 for, 153,921 against.
- Annual meeting held on June 7, 2023; quorum of 7,735,458 shares present.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465923070864/0001104659-23-070864-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465923070864/tm2318518d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-070864

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer